Category: Business

Neuroleptic Malignant Syndrome Market Outlook Neuroleptic Malignant Syndrome (NMS) is a rare, but potentially life-threatening neurological disorder caused by adverse reactions to certain medications, particularly antipsychotic therapies. It is characterized by severe muscle rigidity, fever, altered mental status, and autonomic instability. The market outlook for NMS focuses on improved awareness and early detection, as well as the development of safer antipsychotic medications with lower risk profiles. Ongoing research aims to better understand NMS pathophysiology and develop effective treatment strategies to reduce morbidity and mortality associated with this condition.